Shahzad R, Koerniati S, Harlina P, Hastilestari B, Djalovic I, Prasad P
BMC Plant Biol. 2025; 25(1):170.
PMID: 39924529
PMC: 11808985.
DOI: 10.1186/s12870-025-06180-y.
Yoon H, Jang Y, Paik H, Choi H, Choi J, Kwon J
Lab Anim Res. 2025; 41(1):3.
PMID: 39815341
PMC: 11737197.
DOI: 10.1186/s42826-025-00234-w.
Fadzil M, Abu Seman N, Abd Rashed A
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598457
PMC: 11597494.
DOI: 10.3390/ph17111548.
Ghemis L, Goriuc A, Minea B, Botnariu G, Martu M, Entuc M
Diagnostics (Basel). 2024; 14(21).
PMID: 39518420
PMC: 11544947.
DOI: 10.3390/diagnostics14212453.
Krober T, Holzer M, Kerpes R, Mittermeier-Klessinger V, Dawid C, Becker T
J Agric Food Chem. 2024; 72(20):11480-11492.
PMID: 38733562
PMC: 11117401.
DOI: 10.1021/acs.jafc.4c00570.
A novel model for predicting prolonged stay of patients with type-2 diabetes mellitus: a 13-year (2010-2022) multicenter retrospective case-control study.
Tan J, Zhang Z, He Y, Yu Y, Zheng J, Liu Y
J Transl Med. 2023; 21(1):91.
PMID: 36750951
PMC: 9903472.
DOI: 10.1186/s12967-023-03959-1.
Antihyperglycemic effects of leaf extract and .
Goli A, Sato V, Sato H, Chewchinda S, Leanpolchareanchai J, Nontakham J
Pharm Biol. 2023; 61(1):189-200.
PMID: 36625086
PMC: 9848344.
DOI: 10.1080/13880209.2022.2160771.
The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis.
Xu C, He L, Zhang J, Xu L, Dong J, Liao L
Metabolites. 2022; 12(10).
PMID: 36295882
PMC: 9610220.
DOI: 10.3390/metabo12100979.
A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.
Assaad-Khalil S, Elkafrawy N, Khaled M, Mogeib O, Badr H, Rashwan A
Evid Based Complement Alternat Med. 2022; 2022:9176026.
PMID: 36204125
PMC: 9532066.
DOI: 10.1155/2022/9176026.
Amelioration of obesity-related metabolic disorders via supplementation of in rats fed with a high-fat and high-cholesterol diet.
Manoppo J, Nurkolis F, Pramono A, Ardiaria M, Murbawani E, Yusuf M
Front Nutr. 2022; 9:1010867.
PMID: 36185651
PMC: 9521187.
DOI: 10.3389/fnut.2022.1010867.
Genus and Compound Activities in the Management of Diabetes Mellitus.
Akinfenwa A, Sagbo I, Makhaba M, Mabusela W, Hussein A
Plants (Basel). 2022; 11(10).
PMID: 35631811
PMC: 9143910.
DOI: 10.3390/plants11101386.
Effect of Traditional Cooking and In Vitro Gastrointestinal Digestion of the Ten Most Consumed Beans from the Fabaceae Family in Thailand on Their Phytochemicals, Antioxidant and Anti-Diabetic Potentials.
Tungmunnithum D, Drouet S, Lorenzo J, Hano C
Plants (Basel). 2022; 11(1).
PMID: 35009070
PMC: 8747412.
DOI: 10.3390/plants11010067.
Phytochemical Profile, α-Glucosidase, and α-Amylase Inhibition Potential and Toxicity Evaluation of Extracts from (L) Peel, a Valuable By-Product from Northeastern Morocco.
Benayad O, Bouhrim M, Tiji S, Kharchoufa L, Addi M, Drouet S
Biomolecules. 2021; 11(11).
PMID: 34827553
PMC: 8615658.
DOI: 10.3390/biom11111555.
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus.
Blahova J, Martiniakova M, Babikova M, Kovacova V, Mondockova V, Omelka R
Pharmaceuticals (Basel). 2021; 14(8).
PMID: 34451903
PMC: 8398612.
DOI: 10.3390/ph14080806.
Linking the Phytochemicals and the α-Glucosidase and α-Amylase Enzyme Inhibitory Effects of Seed Extracts.
Tiji S, Bouhrim M, Addi M, Drouet S, Lorenzo J, Hano C
Foods. 2021; 10(8).
PMID: 34441595
PMC: 8393492.
DOI: 10.3390/foods10081818.
Role of Postbiotics in Diabetes Mellitus: Current Knowledge and Future Perspectives.
Cabello-Olmo M, Arana M, Urtasun R, Encio I, Barajas M
Foods. 2021; 10(7).
PMID: 34359462
PMC: 8306164.
DOI: 10.3390/foods10071590.
Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.
Nie X, Chen Z, Pang L, Wang L, Jiang H, Chen Y
Int J Nanomedicine. 2020; 15:10215-10240.
PMID: 33364755
PMC: 7751584.
DOI: 10.2147/IJN.S285134.
Alginate: From Food Industry to Biomedical Applications and Management of Metabolic Disorders.
Gheorghita Puscaselu R, Lobiuc A, Dimian M, Covasa M
Polymers (Basel). 2020; 12(10).
PMID: 33092194
PMC: 7589871.
DOI: 10.3390/polym12102417.
Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.
Hashiesh H, Meeran M, Sharma C, Sadek B, Al Kaabi J, Ojha S
Nutrients. 2020; 12(10).
PMID: 32998300
PMC: 7599522.
DOI: 10.3390/nu12102963.